Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ACELRX PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-20 to 2022-09-24
Current total value of award: $935283
Description: DSUVIA MOD P00002 INCORPORATES NEW CLIN 1004 FOR STORAGE.